Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Researchers race to put hydroxychloroquine to the test in a large study.
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
This year, World Malaria Day is happening as countries around the world are fighting the COVID-19 pandemic.
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.